Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 700 of 885 entries
View as:

Daratumumab Retreatment in Participants With Multiple Myeloma Who Have Been Previously Treated With Daratumumab

Phase: N/A Priority: Normal
NCT ID: NCT03871829 Org: User:
Start: 05/31/19 End: 01/10/23 Due: 01/10/24

A Study to Assess the Effects of Acid-Reducing Agent(s) on JNJ-64417184 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT04453189 Org: User:
Start: 07/20/20 End: 09/14/20 Due: 09/14/21

A Pharmacokinetic Interaction Study Between Odalasvir, Given as a Single Agent or in Combination With Simeprevir, and Dabigatran Etexilate Mesylate in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT02945020 Org: User:
Start: 11/10/16 End: 01/20/17 Due: 01/20/18

Safety & Immunogenicity of JNJ-64041757, Live-attenuated Double-deleted Listeria Immunotherapy, in Subjects With Non Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02592967 Org: User:
Start: 12/02/15 End: 10/22/18 Due: 10/22/19

A Study of JNJ-64281802 in Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT05201937 Org: User:
Start: 02/23/22 End: 12/11/22 Due: 12/11/23

A Study to Evaluate Safety and Immunogenicity of the ExPEC4V Clinical Trial Material After a Single Intramuscular Dose and a Second Dose 6 Months Later in Healthy Participants Aged 18 Years and Older

Phase: N/A Priority: Normal
NCT ID: NCT03500679 Org: User:
Start: 05/09/18 End: 06/11/19 Due: 06/11/20

A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of Canagliflozin in Older Children and Adolescents With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT02000700 Org: User:
Start: 03/31/14 End: 04/30/16 Due: 04/30/17

The CANTATA-D Trial (CANagliflozin Treatment and Trial Analysis - DPP-4 Inhibitor Comparator Trial)

Phase: N/A Priority: Normal
NCT ID: NCT01106677 Org: User:
Start: 05/31/10 End: 05/31/12 Due: 05/31/13

Optimizing Clinical Screening and Management of Maternal Mental Health: Predicting Women at Risk for Perinatal Depression

Phase: N/A Priority: Normal
NCT ID: NCT03144752 Org: User:
Start: 04/14/17 End: 05/05/19 Due: 05/05/20

CANagliflozin Treatment And Trial Analysis-Sulfonylurea (CANTATA-SU) SGLT2 Add-on to Metformin Versus Glimepiride

Phase: N/A Priority: Normal
NCT ID: NCT00968812 Org: User:
Start: 09/30/09 End: 01/31/13 Due: 01/31/14

A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of JNJ-63723283, an Anti-PD-1 Monoclonal Antibody, in Participants With Advanced Cancers

Phase: N/A Priority: Normal
NCT ID: NCT02908906 Org: User:
Start: 11/21/16 End: 10/24/25 Due: 10/24/26

A Single Ascending Dose Study of JNJ-88260237 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05541315 Org: User:
Start: 09/14/22 End: 05/09/23 Due: 05/09/24

Study of Subcutaneous and Intravenous Velcade in Combination With Dexamethasone in Chinese Subjects With Relapsed and Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT02811978 Org: User:
Start: 09/27/16 End: 11/10/18 Due: 11/10/19

A Study to Determine the Effect of Food on the Pharmacokinetics of PCI-32765

Phase: N/A Priority: Normal
NCT ID: NCT01820936 Org: User:
Start: 03/31/13 End: 06/30/13 Due: 06/30/14

A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients

Phase: N/A Priority: Normal
NCT ID: NCT00207688 Org: User:
Start: 08/31/04 End: 09/09/15 Due: 09/09/16

An Efficacy, Safety, and Tolerability Study of Canagliflozin in the Treatment of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Monotherapy

Phase: N/A Priority: Normal
NCT ID: NCT01340664 Org: User:
Start: 07/31/11 End: 04/30/12 Due: 04/30/13

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-39439335 in Healthy Japanese and Caucasian Adult Male Participants

Phase: N/A Priority: Normal
NCT ID: NCT01631487 Org: User:
Start: 07/31/12 End: 03/31/13 Due: 03/31/14

A Study to Assess the Effects of Itraconazole and Rifampicin on the Single-Dose Pharmacokinetics of JNJ-53718678 in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT02729467 Org: User:
Start: 03/31/16 End: 06/30/16 Due: 06/30/17

Study to Assess the Effects of Esketamine on Safety of On-road Driving in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT02228239 Org: User:
Start: 09/30/14 End: 12/31/14 Due: 12/31/15

A Study of Trabectedin or Dacarbazine for the Treatment of Patients With Advanced Liposarcoma or Leiomyosarcoma

Phase: N/A Priority: Normal
NCT ID: NCT01343277 Org: User:
Start: 06/30/11 End: 04/30/16 Due: 04/30/17

A Study to Investigate the Pharmacokinetics, Safety, and Tolerability of Odalasvir and AL-335 Alone and in Combination With Simeprevir in Participants With Moderately Impaired Hepatic Function

Phase: N/A Priority: Normal
NCT ID: NCT03277755 Org: User:
Start: 09/11/17 End: 12/22/17 Due: 12/22/18

A Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti -Tumor Necrosis Factor (TNF) Alpha Agent(s)

Phase: N/A Priority: Normal
NCT ID: NCT03162796 Org: User:
Start: 08/24/17 End: 11/18/19 Due: 11/18/20

Safety & Immunogenicity of JNJ-64041809, a Live Attenuated Double-deleted Listeria Immunotherapy, in Participants With Metastatic Castration-resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02625857 Org: User:
Start: 12/10/15 End: 07/03/18 Due: 07/03/19

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-61803534 and to Evaluate the Effect of JNJ-61803534 on the Pharmacokinetics of Midazolam in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT03139500 Org: User:
Start: 05/17/17 End: 04/05/18 Due: 04/05/19

A Study of JNJ-80038114 in Participants With Advanced Stage Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05441501 Org: User:
Start: 11/15/22 End: 03/31/24 Due: 03/31/25